Table 1.

Patient demographics

Characteristic	Treated patients (N = 20)
Gender, male [n (%)]	10 (50)
Race, Japanese [n (%)]	20 (100)
Age, years [median (range)]	62.5 (29–76)
M stage at study entry [n (%)]
M0	1 (5)
M1a	1 (5)
M1b	4 (20)
M1c	14 (70)
ECOG performance status [n (%)]
0	14 (70)
1	6 (30)
Baseline LDH [n (%)]
Normal	8 (40)
Elevated	12 (60)
Prior systemic anticancer therapy [n (%)]
Yes	16 (80)
No	4 (20)

ECOG Eastern Cooperative Oncology Group, LDH lactate dehydrogenase